Editorial: Developing personalized treatment in neurodegenerative disorders: role of genomics and novel technologies in identifying actionable targets and developing interventions in rare-diseases

• Anja Kovanda,
• Anja Kovanda,
• Sabina Vatovec,
• Valentino Rački

Affiliations

Anja Kovanda

Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

Anja Kovanda

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Sabina Vatovec

Novartis, Ljubljana, Slovenia

Valentino Rački

Faculty of Medicine, University of Rijeka, Rijeka, Croatia